Caas Capital Management LP Stryker Corp Call Options Transaction History

Caas Capital Management LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 26, 2024	BUY	$293.94 - $358.71 $646,668 - $789,162	2,200 Added 157.14%	3,600 $1.29 Million
Q4 2023 Feb 14, 2024	BUY	$253.85 - $299.46 $355,390 - $419,244	1,400 New	1,400 $419,000
Q1 2023 May 15, 2023	BUY	$246.13 - $285.47 $24,613 - $28,547	100 Added 2.86%	3,600 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$205.51 - $253.93 $719,285 - $888,755	3,500 New	3,500 $855,000

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $138B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.